Marc Trellu

Reversibility of the anti‐FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion

Isabelle Paty, Marc Trellu, J.M. Destors et al. · Journal of Thrombosis and Haemostasis · 2010 · 60 citations

Medicine, Pharmaceutics, Pharmacology +6

A G protein–biased S1P ₁ agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers

Bruno Poirier, Véronique Briand, Dieter Kadereit et al. · Science Signaling · 2020 · 40 citations

Life Sciences, Immunology, Pharmacology +7

The pharmacokinetics of idraparinux, a long-acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials

Christine Veyrat‐Follet, Nicole Vivier, Marc Trellu et al. · Journal of Thrombosis and Haemostasis · 2009 · 37 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans

Marc Trellu, Daniel Francon, Rodney D. Adam et al. · Fundamental and Clinical Pharmacology · 2004 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

SAR340835, a Novel Selective Na+/Ca2+ Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure

Michel Pelat, Fabrice Barbe, Cyril Daveu et al. · Journal of Pharmacology and Experimental Therapeutics · 2021 · 14 citations · Full text

Medicine, Cardiology, Pharmacology +17